{"id":4257,"date":"2022-06-17T17:34:06","date_gmt":"2022-06-17T08:34:06","guid":{"rendered":"https:\/\/www.peptide.co.jp\/en\/?page_id=4257"},"modified":"2024-08-26T13:38:07","modified_gmt":"2024-08-26T04:38:07","slug":"rgd-peptides","status":"publish","type":"page","link":"https:\/\/www.peptide.co.jp\/en\/support\/useful\/rgd-peptides","title":{"rendered":"RGD Peptides"},"content":{"rendered":"

Here we introduce product list of RGD Peptides. RGD sequences are commonly seen in cell adhesive proteins.<\/b>
\n\u3000
\n\u3000
\n\u3000<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Code<\/th>\nCompound<\/th>\n<\/th>\n<\/tr>\n
4171<\/a><\/td>\nFibronectin Active Fragment (RGDS)<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
4171-v<\/a><\/td>\nFibronectin Active Fragment (RGDS) <\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
4189<\/a><\/td>\nFibronectin Active Fragment (GRGDS)<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
4189-v<\/a><\/td>\nFibronectin Active Fragment (GRGDS) <\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
4304<\/a><\/td>\ncyclo<\/i>(Arg-Gly-Asp-D<\/font>-Phe-Val)<\/strong><\/span><\/td>\nAngiogenesis Inhibitor<\/td>\n<\/tr>\n
4304-v<\/a><\/td>\ncyclo<\/i>(Arg-Gly-Asp-D<\/font>-Phe-Val)<\/strong><\/span><\/td>\nAngiogenesis Inhibitor<\/td>\n<\/tr>\n
4532<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Phe-Lys)<\/strong><\/span><\/td>\n\u03b1v\u00df3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide(Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
4532-v<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Phe-Lys)<\/strong><\/span><\/td>\n\u03b1v\u00df3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide(Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
CAN-3505-PI<\/a><\/td>\nH-[Lys-Leu-Ala-Lys-Leu-Ala-Lys]2-Gly-Phe-Leu-Gly-(Cys-Gln-Thr-Pro-Tyr-Tyr-Met-Asn-Thr-Cys)-OH<\/strong><\/span><\/td>\nCell Penetrating Peptide (CPP). Targets EGFR, Binding to a Specific Protein in Carcinoma Cells, and Induces Apoptosis.<\/td>\n<\/tr>\n
ECT-3760-PI<\/a><\/td>\nEchistatin<\/strong><\/span><\/td>\n\u03b1V\u00df3 Integrin Antagonist<\/td>\n<\/tr>\n
FAP-3758-PI<\/a><\/td>\nFibronectin Adhesion-Promoting Peptide<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCA-3618-PI<\/a><\/td>\nCyclo(Arg-Ala-Asp-D-Phe-Val)<\/strong><\/span><\/td>\nNegative Control for 4304<\/td>\n<\/tr>\n
PCI-3651-PI<\/a><\/td>\nH-Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 <\/strong><\/span><\/td>\n\u03b1v\u00df3 Integrin Binding RGD Peptide; RGD Tumor Targeting Peptide (Requires further derivatization before use)<\/td>\n<\/tr>\n
PCI-3662-PI<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Tyr-Lys)<\/strong><\/span><\/td>\n\u03b1v\u00df3 Integrin Binding RGD Peptide RGD Tumor Targeting and Tumor Imaging Peptide (Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
PCI-3686-PI<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Phe-Cys)<\/strong><\/span><\/td>\nRGD Tumor Targeting Peptide (linker additions via Cys) (May Require Further Derivatization Before Use)<\/td>\n<\/tr>\n
PCI-3687-PI<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Phe-Glu)<\/strong><\/span><\/td>\nRGD Peptide for Radiolabeling and Imaging (Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
PCI-3688-PI<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Tyr-Glu)<\/strong><\/span><\/td>\nRGD Peptide for Radiolabeling (Requires further derivatization before use)<\/td>\n<\/tr>\n
PCI-3696-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG)]<\/strong><\/span><\/td>\nRGD Peptide Equipped with PEG Spacers for More Efficient Binding to Lipid Surfaces(Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
PCI-3697-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(Biotin-PEG-PEG)]<\/strong><\/span><\/td>\nRGD Peptide Equipped with a Biotin Reporting Tag and PEG Spacers for More Efficient Binding to Lipid Surfaces (Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
PCI-3699-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(Ac-SCH2CO)]<\/strong><\/span><\/td>\nRGD Peptide Equipped with Thioacetyl Group for Linking to Liposomes (May Require Further Derivatization and Deprotection Before Use)<\/td>\n<\/tr>\n
PCI-3790-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(dPEG\u00ae4)]<\/strong><\/span><\/td>\nRGD Tumor Targeting (and With Radiolabeling, A Tumor Imaging Peptide)<\/td>\n<\/tr>\n
PCI-3808-PI<\/a><\/td>\nCyclo[Arg-Ala-Asp-D-Phe-Lys(Biotin-PEG-PEG)]<\/strong><\/span><\/td>\nNegative Control Peptide for PCI-3697-PI<\/td>\n<\/tr>\n
PCI-3823-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG-Cys)]<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3861-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Tyr-Lys(Cys-AEEA-DOTA)]<\/strong><\/span><\/td>\nRGD Peptide Functionalized with a Radiometal Chelator, DOTA (1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid); Potentially Useful for Tumor Targeting and Imaging.<\/td>\n<\/tr>\n
PCI-3883-PI<\/a><\/td>\nCyclo(Arg-Ala-Asp-D-Phe-Lys)<\/strong><\/span><\/td>\nNegative Control RGD Peptide for 4532<\/td>\n<\/tr>\n
PCI-3894-PI<\/a><\/td>\nCyclo(Arg-Ala-Asp-D-Tyr-Lys)<\/strong><\/span><\/td>\nControl Peptide of cyclo (Arg-Gly-Asp-D-Tyr-Lys) (PCI-3662-PI)<\/td>\n<\/tr>\n
PCI-3895-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(Biotin)]<\/strong><\/span><\/td>\nRGD Peptide Equipped with a Biotin Reporting Tag<\/td>\n<\/tr>\n
PCI-3898-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(H-Ser)]<\/strong><\/span><\/td>\n\u03b1v\u00df3 Integrin Binding RGD Peptide; RGD Tumor Targeting Peptide (Requires further derivatization before use)<\/td>\n<\/tr>\n
PCI-3899-PI<\/a><\/td>\nH-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2<\/strong><\/span><\/td>\nTumor Targeting and Tumor Imaging Peptide (Requires Further Derivatization Before Use)<\/td>\n<\/tr>\n
PCI-3903-PI<\/a><\/td>\nDOTA-Glu-[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2<\/strong><\/span><\/td>\n\u03b1v\u00df3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide for Radiolabelling (Requires further derivatization before use)<\/td>\n<\/tr>\n
PCI-3904-PI<\/a><\/td>\nH-Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2<\/strong><\/span><\/td>\nRGD Tumor Targeting and Tumor Imaging Peptide (Requires further derivatization before use)<\/td>\n<\/tr>\n
PCI-3909-PI<\/a><\/td>\nH-Gly-Arg-Gly-Asp-Asn-Pro-OH<\/strong><\/span><\/td>\nRGD peptide and Inhibitor of Cell Adhesion to Fibronectin<\/td>\n<\/tr>\n
PCI-3910-PI<\/a><\/td>\nH-Gly-Arg-Ala-Asp-Ser-Pro-OH<\/strong><\/span><\/td>\nNegative Control for Fibronectin Inhibitors<\/td>\n<\/tr>\n
PCI-3912-PI<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Tyr-Cys)<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3917-PI<\/a><\/td>\nCyclo(Arg-Ala-Asp-D-Tyr-Cys)<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3919-PI<\/a><\/td>\nCyclo(Arg-Gly-Asp-D-Phe-Lys)<\/strong><\/span><\/td>\nRGD Tumor Targeting Peptide (Requires further derivatization before use)<\/td>\n<\/tr>\n
PCI-3929-PI<\/a><\/td>\nH-Arg-Gly-Asp-Ser-Lys-OH<\/strong><\/span><\/td>\nRGD Tumor-Targeting Peptide<\/td>\n<\/tr>\n
PCI-3930-PI<\/a><\/td>\nH-Arg-Ala-Asp-Ser-Lys-OH<\/strong><\/span><\/td>\nNegative Control for PLI-3929-PI<\/td>\n<\/tr>\n
PCI-3953-PI<\/a><\/td>\nCyclo(Arg-Gly-Glu-D-Phe-Lys)<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3954-PI<\/a><\/td>\nCyclo[Arg-Ala-Asp-D-Phe-Lys(PEG-PEG)]<\/strong><\/span><\/td>\nNegative Control Peptide for PCI-3696-PI<\/td>\n<\/tr>\n
PCI-3959-PI<\/a><\/td>\nCyclo[Arg-Ala-Asp-D-Phe-Lys(Ac-SCH2CO)]<\/strong><\/span><\/td>\nControl for PCI-3699-PI<\/td>\n<\/tr>\n
PCI-3960-PI<\/a><\/td>\nCyclo(Arg-Ala-Asp-D-Phe-Cys)<\/strong><\/span><\/td>\nNegative Control Peptide for PCI-3686-PI<\/td>\n<\/tr>\n
PCI-3963-PI<\/a><\/td>\nH-Pro-His-Ser-Arg-Asn-OH<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3964-PI<\/a><\/td>\nH-Gly-Asp-Gly-Val-D-Ile-Thr-Arg-Ile-Arg-OH<\/strong><\/span><\/td>\nCD36 Binding Peptide<\/td>\n<\/tr>\n
PCI-3965-PI<\/a><\/td>\nH-Gly-Gly-Gly-Gly-Arg-Gly-Asp-Ser-Pro-OH<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3975-PI<\/a><\/td>\nH-Glu{Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2<\/strong><\/span><\/td>\nTetrameric RGD Peptide<\/td>\n<\/tr>\n
PCI-3977-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-COCH2CH2SH)]<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
PCI-3979-PI<\/a><\/td>\nH-Glu[Cyclo(Arg-Ala-Asp-D-Phe-Lys)]2<\/strong><\/span><\/td>\nNegative Control Peptide for PCI-3651-PI<\/td>\n<\/tr>\n
PFA-3907-PI<\/a><\/td>\nH-Gly-Arg-Gly-Glu-Ser-OH<\/strong><\/span><\/td>\nNegative Control for 4189-v<\/td>\n<\/tr>\n
PFA-3924-PI<\/a><\/td>\nAc-Gly-D-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-(Gly)4-Ser-D-Arg-(Leu)6-D-Arg-NH2<\/strong><\/span><\/td>\nHydrophobic RGD Fibronectin Peptide<\/td>\n<\/tr>\n
RGD-3000-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Tyr-Lys(PEG)]<\/strong><\/span><\/td>\n<\/td>\n<\/tr>\n
RGD-3005-PI<\/a><\/td>\nCyclo[Arg-Ala-Asp-D-Tyr-Lys(PEG)]<\/strong><\/span><\/td>\nControl peptide for RGD-3000-PI<\/td>\n<\/tr>\n
RGD-3035-PI<\/a><\/td>\nAc-cyclo [Pen-Tyr(Me)-Ala-Arg-Gly-Asp-Asn-Tic-Cys]-NH2<\/strong><\/span><\/td>\nCell Penetrating Peptide That Targets EGFR, Binds to a Specific Protein in Carcinoma Cells, and Induces Apoptosis<\/td>\n<\/tr>\n
RGD-3506-PI<\/a><\/td>\nH-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH<\/strong><\/span><\/td>\nThiolated Cell Adhesion Peptide<\/td>\n<\/tr>\n
RGD-3736-PI<\/a><\/td>\nGalactosyl-Cyclo(Arg-Gly-Asp-D-Phe-Lys)<\/strong><\/span><\/td>\nGlycosylated RGD for Radiolabelling<\/td>\n<\/tr>\n
RGD-3749-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(Azide)]<\/strong><\/span><\/td>\nClickable RGD for Dendrimer Constructs<\/td>\n<\/tr>\n
RGD-3750-PI<\/a><\/td>\nH-dPEG\u00ae4-Glu[dPEG\u00ae4(Cyclo(Arg-Gly-Asp-d-Phe-Lys))]2<\/strong><\/span><\/td>\nFor In Vitro Assays of Integrin \u03b1v\u00df3\/\u03b1v\u00df5 Expression in Tumor Tissues<\/td>\n<\/tr>\n
RGD-3759-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG-Azide)]<\/strong><\/span><\/td>\nClickable RGD for Dendrimer Constructs<\/td>\n<\/tr>\n
RGD-3761-PI<\/a><\/td>\nH-[Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys]-NH2<\/strong><\/span><\/td>\nRGD Tumor Targeting Peptide<\/td>\n<\/tr>\n
RGD-3762-PI<\/a><\/td>\nH-[Cys-Arg-Gly-Asp-Arg-Gly-Pro-Asp-Cys]-NH2<\/strong><\/span><\/td>\nRGD Tumor Targeting Peptide<\/td>\n<\/tr>\n
RGD-3766-PI<\/a><\/td>\nH-AEEEA-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2<\/strong><\/span><\/td>\nBicyclic RGD Peptide for Imaging<\/td>\n<\/tr>\n
RGD-3782-PI<\/a><\/td>\nGalacto-RGD2<\/strong><\/span><\/td>\nDdimer<\/td>\n<\/tr>\n
RGD-3794-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(Cys)]<\/strong><\/span><\/td>\nRGD Peptide for Radiolabeling and Imaging<\/td>\n<\/tr>\n
RGD-3795-PI<\/a><\/td>\nCyclo[Arg-Gly-Asp-D-Phe-Lys(Mal)]<\/strong><\/span><\/td>\nRGD Peptide With 3-Maleimidopropionic Acid Functional Group<\/td>\n<\/tr>\n
RGD-3842-PI<\/a><\/td>\nCyclo[Arg-Ala-Asp-D-Phe-Lys(Azide)]<\/strong><\/span><\/td>\nNegative Control Peptide for RGD-3749-PI<\/td>\n<\/tr>\n
RGD-3879-PI<\/a><\/td>\nN3-PEG-PEG3-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2<\/strong><\/span><\/td>\nBicyclic RGD peptide Optimized for Click Chemistry<\/td>\n<\/tr>\n
RGD-3993-PI<\/a><\/td>\nMal-PEG3-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2<\/strong><\/span><\/td>\nDimeric RGD peptide for click chemistry<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Here we introduce product list of RGD Peptides. RGD sequences are commonly seen in cell adhesive proteins. \u3000 \u3000 […]<\/p>\n","protected":false},"author":4,"featured_media":996,"parent":100,"menu_order":440,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/4257"}],"collection":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/comments?post=4257"}],"version-history":[{"count":6,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/4257\/revisions"}],"predecessor-version":[{"id":5508,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/4257\/revisions\/5508"}],"up":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/pages\/100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/media\/996"}],"wp:attachment":[{"href":"https:\/\/www.peptide.co.jp\/en\/wp-json\/wp\/v2\/media?parent=4257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}